Abstract
Objective: Preliminary findings suggest a relationship between lower serum 25-hydroxyvitamin D [25(OH)D] levels and incidence and severity of COVID-19. The aim of this study was to evaluate the relationship between vitamin D status at admission and different markers of inflammation, coagulation, and sepsis in hospitalized patients with COVID-19.
Method: We conducted a retrospective study on 137 consecutive patients with SARS-CoV-2 infection and available data on serum 25(OH)D levels, who were admitted to our Institution between March 1 and April 30, 2020. Patients were divided into two groups: survivors (n = 78; 57%) and non-survivors (n = 59; 43%).
Results: At admission, all patients showed hypovitaminosis D. Median total serum 25(OH)D levels at admission were significantly higher in survivors than non-survivors (12 ng/mL vs 8 ng/mL; p < 0.01). Non-survivors exhibited significantly higher median levels of white blood cell (WBC) count, neutrophil-to-lymphocyte count ratio (NLR), high-sensitivity C-reactive protein (hsCRP), ferritin, interleukin 6 (IL-6), D-dimer, fibrinogen, and procalcitonin (PCT) compared to survivors at three different time points during hospitalization. In a multivariate analysis performed by a logistic regression model, serum 25(OH)D levels were significantly inversely associated with risk of COVID-19-related in-hospital mortality (odds ratio, 0.91; 95% confidence interval, 0.85-0.98; p = 0.01). According to receiver operating characteristic curve analysis, hsCRP, NLR, ferritin, and D-dimer were the best predictive biomarkers for poor prognosis of COVID-19, whereas IL-6, PCT, fibrinogen, 25(OH)D, WBC count, and tumor necrosis factor alpha (TNF-α) may serve as supportive biomarkers for worse clinical course of the disease.
Conclusions: We found a markedly high prevalence (100%) of hypovitaminosis D in patients admitted to hospital with COVID-19, suggesting a possible role of low vitamin D status in increasing the risk of SARS-CoV-2 infection and subsequent hospitalization. The inverse association between serum 25(OH)D levels and risk of in-hospital mortality observed in our cohort suggests that a lower vitamin D status upon admission may represent a modifiable and independent risk factor for poor prognosis in COVID-19.
Keywords: COVID-19; SARS-CoV-2; Vitamin D status; cytokine storm; inflammatory markers; mortality.
【저자키워드】 COVID-19, SARS-CoV-2, Cytokine storm, inflammatory markers, mortality., Vitamin D status, 【초록키워드】 Inflammation, Necrosis, Tumor, Cytokine storm, Biomarker, Mortality, Vitamin D, Hospitalization, IL-6, SARS-COV-2 infection, 25-hydroxyvitamin D, hospital, neutrophil, inflammatory markers, C-reactive protein, risk, D-dimer, ferritin, procalcitonin, Sepsis, cytokine, hospitalized patients, interleukin 6, Coagulation, Prevalence, Retrospective study, lymphocyte, serum, Cohort, Clinical course, Hospital mortality, hsCRP, interleukin, tumor necrosis factor, White blood cell, severity of COVID-19, Patient, Alpha, fibrinogen, Vitamin, WBC, incidence, characteristic, Admission, in-hospital mortality, TNF-α, association, Multivariate analysis, marker, NLR, Vitamin D status, Analysis, Inflammatory, Hypovitaminosis D, Odds ratio, best, blood cell, Predictive, receiver operating characteristic, tumor necrosis, tumor necrosis factor alpha, Non-survivors, High-sensitivity C-reactive protein, two groups, available data, 95% confidence interval, institution, logistic regression model, poor prognosis, serum 25-hydroxyvitamin D, independent risk factor, count, WBC count, survivor, preliminary findings, PCT, non-survivor, hypovitaminosis, performed, evaluate, significantly, subsequent, the disease, conducted, exhibited, median, hospitalized patient, significantly higher, different time point, consecutive patient, with COVID-19, 【제목키워드】 Factor, status, Italian, Poor,